InMed Pharmaceuticals Inc.
INM | NASDAQ
$13.21
-$4.29 (-24.53%)
At close: Nov 5, 2026, 4:00 PM ET
$14.00
+$0.79 (+5.98%)
After-hours:
Nov 5, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2026 Jun 30, 2026 | FY 2025 Jun 30, 2025 | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | 3.18B | 4.94M | 4.6M | 4.14M | 1.09M | n/a |
Cost of Revenue | 2.47B | 3.24M | 3.5M | 2.73M | 545.89K | n/a |
Gross Profit | 709.84M | 1.71M | 1.1M | 1.4M | 543.55K | n/a |
Operating Income | -9.9M | -7.92M | -8.13M | -8.38M | -13.79M | -12.17M |
Interest Income | 244.97K | 156.54K | 721.97K | 652.37K | 123.72K | 16.02K |
Pretax Income | -11.37M | -8.16M | -7.67M | -7.93M | -18.6M | -12.65M |
Net Income | -12.56M | -8.16M | -7.68M | -7.95M | -18.6M | -12.65M |
Selling & General & Admin | 1.88B | 6.56M | 5.8M | 5.85M | 6.87M | 5.55M |
Research & Development | 15.13M | 2.85M | 3.22M | 3.73M | 7.28M | 6.62M |
Other Expenses | -1.89B | 212.84K | 219.6K | 202.25K | 185.66K | n/a |
Operating Expenses | 9.19M | 9.62M | 9.24M | 9.78M | 14.34M | 12.17M |
Interest Expense | 10.7K | 373.11K | n/a | n/a | n/a | 360.35K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 9.9M | 12.86M | 12.73M | 12.51M | 14.88M | 12.17M |
Income Tax Expense | n/a | n/a | 7.1K | 13.1K | n/a | n/a |
Shares Outstanding (Basic) | 4.16M | 975.99K | 381.05K | 122.42K | 1.12K | 13.44K |
Shares Outstanding (Diluted) | 4.16M | 975.99K | 381.05K | 122.42K | 1.12K | 13.44K |
EPS (Basic) | -3.12 | -8.36 | -20.14 | -64.92 | -16.58K | -938.91 |
EPS (Diluted) | -3.12 | -8.36 | -20.14 | -64.92 | -16.58K | -938.91 |
EBITDA | -9.19M | -7.26M | -7.06M | -7.34M | -18.09M | -12.12M |
EBIT | -9.9M | -7.79M | -7.67M | -7.93M | -18.6M | -12.32M |
Depreciation & Amortization | 708.36K | 534.73K | 604.52K | 596K | 511.79K | 197.03K |
Add to Watchlist
Select watchlists to add or remove INM